ConductScience.org, home

Paper41535649

Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer.

Zhang L and 5 others. Discov Oncol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer. Papers, record 41535649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535649

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer.
PubMed
Journal
Discov Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-02-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang LLu
2Zhang QQuan
3Yang MMengjie
4Xu MMengyao
5Li QQiyuan
6Chen QQionghua

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 82271678the National Natural Science Foundation of ChinaPubMed
No. 2022J02058the Natural Science Foundation of Fujian ProvincePubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
239174693Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma.Sci Rep2024https://conductscience.org/library/papers/39174693PubMed
336420154Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/36420154PubMed
432793281Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer.Front Genet2020https://conductscience.org/library/papers/32793281PubMed
536273006Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma.Nat Commun2022https://conductscience.org/library/papers/36273006PubMed
636158685Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma.Front Oncol2022https://conductscience.org/library/papers/36158685PubMed
729344893Profiling Tumor Infiltrating Immune Cells with CIBERSORT.Methods Mol Biol2018https://conductscience.org/library/papers/29344893PubMed
833429363Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing.Aging (Albany NY)2021https://conductscience.org/library/papers/33429363PubMed
924113773Inferring tumour purity and stromal and immune cell admixture from expression data.Nat Commun2013https://conductscience.org/library/papers/24113773PubMed
1029625050Oncogenic Signaling Pathways in The Cancer Genome Atlas.Cell2018https://conductscience.org/library/papers/29625050PubMed
1134724589Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer.Gastric Cancer2022https://conductscience.org/library/papers/34724589PubMed
1236878570Immunotherapy in endometrial cancer.Int J Gynecol Cancer2023https://conductscience.org/library/papers/36878570PubMed
1338596689Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8+ T cells.Front Immunol2024https://conductscience.org/library/papers/38596689PubMed
1434502029Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.Int J Mol Sci2021https://conductscience.org/library/papers/34502029PubMed
1537491281RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.Mil Med Res2023https://conductscience.org/library/papers/37491281PubMed
1622455463clusterProfiler: an R package for comparing biological themes among gene clusters.OMICS2012https://conductscience.org/library/papers/22455463PubMed
1727197262Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.Cancer Res2016https://conductscience.org/library/papers/27197262PubMed
1825605792limma powers differential expression analyses for RNA-sequencing and microarray studies.Nucleic Acids Res2015https://conductscience.org/library/papers/25605792PubMed
1931740819Fast, sensitive and accurate integration of single-cell data with Harmony.Nat Methods2019https://conductscience.org/library/papers/31740819PubMed
2036282174Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.Elife2022https://conductscience.org/library/papers/36282174PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42418064Exploring the mechanism by which triphenyl phosphate promotes malignant phenotypes in bladder and kidney cancer through MMP9 based on bioinformatics analysis and experimental validation.Clin Exp Med2026https://conductscience.org/library/papers/42418064

Source PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDK165127PubTator's text mininghttps://conductscience.org/library/genes/5127NCBI Gene
CIT11113PubTator's text mininghttps://conductscience.org/library/genes/11113NCBI Gene
HAPLN11404PubTator's text mininghttps://conductscience.org/library/genes/1404NCBI Gene
LRRN4CL221091PubTator's text mininghttps://conductscience.org/library/genes/221091NCBI Gene
LTB4050PubTator's text mininghttps://conductscience.org/library/genes/4050NCBI Gene
RARRES25919PubTator's text mininghttps://conductscience.org/library/genes/5919NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41535649

GET https://conductscience.org/api/papers/v1/41535649/references?page=2